What does CGM Solutions cost?

Continuous glucose monitoring systems range from $80–$450+ per month depending on brand, insurance status, and procurement strategy.

Without insurance, the annual cost of continuous glucose monitors can range from $2,000 to $4,500 . The actual outlay depends on which system you choose, whether you're buying sensors (the largest recurring expense), transmitters, and receivers—and critically, whether you have insurance coverage or access to manufacturer savings programs. Prescription CGMs dominate the market; over-the-counter models launched in 2024 offer an alternative for non-insulin users at lower entry costs but without insurance reimbursement.

What the typical range is

Prescription CGMs with commercial insurance:

Both major CGM systems typically cost $20 or less per month with commercial insurance, and pharmacy savings cards or copay programs are available for those without coverage or with high copays.

Prescription CGMs without insurance (retail cash price):

FreeStyle Libre products are the least expensive CGM without insurance, at $80–$150/month

Dexcom G7 sensors cost around $80 each and last 10 days, adding up to about $240/month or $3,000–$3,500 annually, not counting transmitters or accessories

Without insurance or discounts, the annual cost of the Dexcom G6 system with a receiver would be about $7,000

Over-the-counter models (no prescription required):

Dexcom Stelo costs $89 for a monthly subscription or $99 for a one-time order of two sensors

Abbott's Lingo OTC costs $49/14-day sensor

These are not covered by insurance and must be paid with HSA/FSA funds or cash.

Implantable option:

Eversense 365 (implanted under the skin, lasts one year) can cost as low as $199 for a full year if commercially insured through the PASS program, including both sensor and transmitter .

What pushes price up — features, certifications, support tier

Sensor wear time and replacement frequency:

Libre 3 offers 14-day wear time; Dexcom G7 offers 10 days; both offer factory-calibrated, real-time glucose monitoring. Longer wear means fewer sensor changes and lower annual consumable costs—critical for procurement budgeting.

Transmitter lifespan:

Transmitters last around three months but cost between $200 and $350 to replace. The newer Eversense 365 eliminates annual transmitter replacement (it lasts 365 days), which can reduce year-two costs if you don't need a new device.

Accuracy and FDA clearance level:

Accuracy is clinically acceptable across all systems, with MARD (Mean Absolute Relative Difference) values generally below 10%. All major systems are FDA-cleared for nonadjunctive use (treatment decisions can be made without fingerstick confirmation). Premium positioning around real-time alerts, smartphone app integration, and pump connectivity does not materially raise unit costs but may affect system selection.

Pump integration and ecosystem:

Dexcom G7 offers the broadest pump integration; Medtronic Simplera integrates exclusively with Medtronic pumps. Facilities already committed to one pump ecosystem may have higher switching costs but no higher CGM device price.

What pushes price down — refurbished, older generation, lease, GPO contracts

Older-generation devices:
Dexcom G6 (superseded by G7) and earlier FreeStyle Libre 2 models remain available through some suppliers and pharmacies at a discount. Check with your DME supplier or pharmacy for stock-clearing inventory.

Manufacturer and pharmacy savings programs:

Dexcom offers $210 off each monthly sensor pack, $230 off a transmitter over 3 months, and more than $200 off the Dexcom G7 receiver, with options for 60- or 90-day supplies at $400 or $600 off respectively.

Companies like Dexcom and Abbott often provide savings cards for eligible patients, reducing monthly costs by $50 or more.

Pharmacy price variation:

FreeStyle Libre sensors have been seen as low as $37/sensor in some pharmacies but over $100 in others; Costco Pharmacy often has the lowest price across the country. Medicare beneficiaries and large institutional buyers should request price verification from multiple DME suppliers.

Medicare pricing:

From July 2022 to June 2023, Medicare payments for CGMs and supplies exceeded suppliers' acquisition costs by $377 million (69 percent) in a year. This suggests hospitals and health systems may negotiate better rates by requesting cost-plus or fixed-price contracts for Medicare-eligible populations.

Hidden costs — install, training, calibration, consumables, service contracts

Sensor insertion and setup (Eversense only):

Eversense 365 is implanted under the skin of the upper arm during a brief in-office procedure performed by a certified healthcare professional. Budget for provider time and medical assistant labor for insertion and removal every 365 days. Other CGMs are user-applied with minimal training.

Calibration requirements:

After the initial two weeks, Eversense 365 requires only weekly calibration, a decrease from daily calibration required in the previous Eversense E3. Most Dexcom and Libre models are factory-calibrated and require no user calibration. Workflow impact is minimal but calibration lancets (fingerstick devices) remain necessary for Eversense users.

Receiver or reader device:

The reader for FreeStyle Libre products costs $65 from the pharmacy but is a one-time purchase, though pharmacies might charge more. Dexcom G7 includes a receiver; many users opt for smartphone-only display (no additional cost if a compatible device exists). Smart devices are non-covered by Medicare because they do not meet the definition of DME.

Adhesive and skin-prep supplies:

Estimate costs do not include accessories, adhesive patches, or unexpected replacements, which can push costs higher. Budget ~$20–50/year per patient for adhesive patches and skin-prep wipes.

Data management and cloud integration:
Dexcom Clarity (clinic sharing), LibreView (Abbott), and Medtronic CareLink (pump data) are included at no additional cost. No separate software licensing fees apply.

How to negotiate — concrete tactics

Request competitive bidding from your DME suppliers.

• Solicit quotes from minimum three DME suppliers (regional and national) for your patient population size.
• Specify whether you need a prescription-based or OTC solution, sensor quantity, and desired wear time.
• Request volume commitments (e.g., "we commit to X patients/year") in exchange for a fixed per-sensor or per-patient-year rate.

Use group purchasing organization (GPO) contracts.
Large health systems and hospital networks often have existing CGM contracts through Vizient, Medline, or HD Supply that bundle discounts across sensors and transmitters. Verify your facility's GPO portfolio and activate these contracts.

Pursue manufacturer co-pay assistance and patient support programs.

• Dexcom and Abbott both operate copay cards and savings vouchers for eligible patients.

Some clinics partner with manufacturers to provide CGMs at little to no cost for uninsured patients, and community programs focused on chronic illness management may distribute discounted supplies.

Negotiate Medicare DME rates in writing.
If your facility is a Medicare-eligible provider, request a written fee schedule from each supplier showing the HCPCS codes (E2102, E2103 for devices; A4238, A4239 for supplies) and their monthly allowances. Medicare Part B payments for CGMs and supplies rose from $109 million in 2018 to $1.3 billion in 2023 , indicating room for negotiation to prevent overpayment.

Ask suppliers to itemize Eversense insertion/removal fees separately.
If adopting Eversense 365, negotiate the CGM device cost separately from the insertion/removal professional fees (which may vary by provider and setting).

When the price feels off — red flags

Transmitter costs exceeding $250–$350:

Transmitters should cost between $200 and $350 to replace. If a supplier quotes higher, request an alternate model or escalate to their regional account manager.

Sensor pricing outside published ranges:
If a pharmacy quotes FreeStyle Libre above $150/sensor pair or Dexcom above $120/sensor, ask about pharmacy pricing tiers and coupon eligibility. Coupons like SingleCare or GoodRx can lower FreeStyle prices to ~$40/sensor, and Abbott maintains a direct program to keep cash prices as low as $40.

Refusal to provide itemized quotes by sensor, transmitter, and receiver.
Demand transparency. Medicare bundling rules (supplies under A4238/A4239) do not prevent you from seeing unit costs. Opaque pricing often hides margin inflation.

Unclear Medicare coverage restrictions:

If a beneficiary never uses a DME receiver or insulin infusion pump to display CGM glucose data, the supply allowance is not covered by Medicare. A supplier claiming a smartwatch-only Dexcom setup is Medicare-covered is misrepresenting policy. Verify HCPCS codes and coverage rules directly with your legal/compliance team.

Supplier unable to confirm iCGM (integrated CGM) status:

Eversense 365 is cleared as an integrated CGM system, meaning it could potentially work with compatible insulin pumps and automated insulin delivery systems in the future. If your facility uses automated insulin delivery, confirm iCGM compatibility in writing before procurement.

Sources

• Centers for Medicare & Medicaid Services. (2022). Continuous glucose monitors — Local Coverage Determination L33822. https://www.cms.gov/medicare-coverage-database
• Natural Endocrinology Specialists. (February 2026). How much do continuous glucose monitors cost in 2025?
• Abbott Diabetes Care. (2024). FreeStyle Libre cost and coverage. https://www.freestyle.abbott
• Dexcom, Inc. (2024–2026). Dexcom CGM pricing and savings center. https://www.dexcom.com
• Senseonics, Inc. (2024). Eversense 365 cost and insurance. https://www.eversensecgm.com
• U.S. Department of Health and Human Services, Office of Inspector General. (December 2025). Medicare payments for continuous glucose monitors and supplies exceeded supplier costs and retail market prices.

---

Note: MedSource does not yet have aggregate quote data for CGM Solutions from health systems and health plans. This article reflects publicly available manufacturer list prices, Medicare fee-for-service allowances, pharmacy retail pricing, and vendor savings programs as of May 2026. As procurement quotes accrue, regional variation, volume discounts, and GPO contract rates will be incorporated into future updates.